
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $115.6M | -- | -- | -$0.05 | -- |
08/01/2025 | Q2 | $112.7M | -- | -- | -$0.03 | -- |
05/01/2025 | Q1 | $116.4M | $111.1M | -$16.49 | -$0.02 | -$16.47 |
02/05/2025 | Q4 | $122.7M | $120.7M | -$3.03 | $0.06 | -$3.09 |
10/30/2024 | Q3 | $121.5M | $116.1M | -$1.72 | -$0.02 | -$1.70 |
08/01/2024 | Q2 | $122M | $111.4M | -$0.57 | -$0.02 | -$0.55 |
04/29/2024 | Q1 | $121.4M | $115.2M | -$0.31 | -$0.01 | -$0.30 |
02/06/2024 | Q4 | $132.2M | $124.5M | $0.50 | $0.02 | $0.47 |
11/01/2023 | Q3 | $126.4M | $129.5M | -$1.01 | $0.07 | -$1.08 |
08/01/2023 | Q2 | $124.7M | $120.4M | $0.15 | $0.07 | $0.08 |
05/01/2023 | Q1 | -- | $121.9M | $3.18 | -- | -- |
02/02/2023 | Q4 | -- | $132.6M | -$2.19 | -- | -- |
11/01/2022 | Q3 | -- | $125.4M | -$0.24 | -- | -- |
08/02/2022 | Q2 | -- | $122.1M | -$9.40 | -- | -- |
05/03/2022 | Q1 | -- | $119.3M | -$1.16 | -- | -- |
02/01/2022 | Q4 | -- | $134.5M | -$0.84 | -- | -- |
10/28/2021 | Q3 | -- | $128M | -$0.36 | -- | -- |
07/29/2021 | Q2 | -- | $125.4M | -$3.07 | -- | -- |
04/29/2021 | Q1 | -- | $122.9M | -$1.14 | -- | -- |
01/28/2021 | Q4 | -- | $131.3M | $0.03 | -- | -- |
10/27/2020 | Q3 | -- | $127.4M | -$0.15 | -- | -- |
07/28/2020 | Q2 | -- | $110.6M | $0.04 | -- | -- |
03/31/2020 | Q1 | -- | $111.4M | $0.01 | -- | -- |
12/31/2019 | Q4 | -- | $133.5M | $0.12 | -- | -- |
10/29/2019 | Q3 | -- | $119.7M | $0.09 | -- | -- |
07/30/2019 | Q2 | -- | $117.7M | $0.20 | -- | -- |
04/30/2019 | Q1 | -- | $115.4M | -$0.08 | -- | -- |
01/29/2019 | Q4 | -- | $131.9M | $0.03 | -- | -- |
10/25/2018 | Q3 | -- | $122.2M | $0.11 | -- | -- |
07/26/2018 | Q2 | -- | $120.6M | $0.04 | -- | -- |
04/26/2018 | Q1 | -- | $123M | $0.02 | -- | -- |
01/25/2018 | Q4 | -- | $136.4M | -$0.23 | -- | -- |
10/26/2017 | Q3 | -- | $126M | $0.16 | -- | -- |
07/27/2017 | Q2 | -- | $119.2M | $0.09 | -- | -- |
04/27/2017 | Q1 | -- | $122.2M | $0.13 | -- | -- |
01/31/2017 | Q4 | -- | $141.5M | $0.27 | -- | -- |
10/27/2016 | Q3 | -- | $129.9M | $0.23 | -- | -- |
07/28/2016 | Q2 | -- | $123.1M | $0.16 | -- | -- |
04/27/2016 | Q1 | -- | $119M | $0.12 | -- | -- |
01/27/2016 | Q4 | -- | $143.5M | $0.34 | -- | -- |
10/26/2015 | Q3 | -- | $129.5M | $0.21 | -- | -- |
Strategy reported $111.1M worth of top line sales in its most recent quarter.
Strategy announced earnings per share of -$16.49 which represents a miss of analyst forecast a -$0.02 per share.
Strategy reported $77.1M that represents $0.30 per share over the last quarter.
Strategy's earnings are forecast to decrease from -$6.06 per share to -$3.08 per share next year representing a decrease of -168.5%.
Strategy's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.